BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38326801)

  • 1. De-obstruction of bladder outlet in humans reverses organ remodelling by normalizing the expression of key transcription factors.
    Akshay A; Gheinani AH; Besic M; Braga S; Uldry AC; Heller M; Rehrauer H; Fournier CA; Burkhard FC; Monastyrskaya K
    BMC Urol; 2024 Feb; 24(1):33. PubMed ID: 38326801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
    Tan AH; Gilling PJ; Kennett KM; Frampton C; Westenberg AM; Fraundorfer MR
    J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of transurethral resection of prostate (TURP) in patients with underactive bladder: 12 months follow-up in different grades of detrusor contractility.
    Lebani BR; Barcelos ADS; Gouveia DSES; Girotti ME; Remaille EP; Skaff M; Almeida FG
    Prostate; 2023 Jun; 83(9):857-862. PubMed ID: 36945749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detrusor underactivity influences the efficacy of TURP in patients with BPO.
    Zhu Y; Zhao YR; Zhong P; Qiao BM; Yang ZQ; Niu YJ
    Int Urol Nephrol; 2021 May; 53(5):835-841. PubMed ID: 33386583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update.
    Cornu JN; Ahyai S; Bachmann A; de la Rosette J; Gilling P; Gratzke C; McVary K; Novara G; Woo H; Madersbacher S
    Eur Urol; 2015 Jun; 67(6):1066-1096. PubMed ID: 24972732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
    Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of bladder vascular resistance before and after prostatic surgery in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    Wada N; Watanabe M; Kita M; Matsumoto S; Kakizaki H
    Neurourol Urodyn; 2012 Jun; 31(5):659-63. PubMed ID: 22488529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The resolution of detrusor over activity after medical and surgical treatment in patients with bladder outlet obstruction.
    Sriplakich S; Promwatcharanon K
    J Med Assoc Thai; 2007 Nov; 90(11):2326-31. PubMed ID: 18181315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanical stop test and isovolumetric detrusor contractile reserve are associated with immediate spontaneous voiding after transurethral resection of prostate.
    Dobberfuhl AD; Zhang X; Comiter CV
    Int Urol Nephrol; 2020 Feb; 52(2):239-246. PubMed ID: 31673936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified bladder outlet obstruction index for powerful efficacy prediction of transurethral resection of prostate with benign prostatic hyperplasia.
    Liu H; Tian Y; Luo G; Su Z; Ban Y; Wang Z; Sun Z
    BMC Urol; 2021 Dec; 21(1):170. PubMed ID: 34872539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction.
    Thomas AW; Cannon A; Bartlett E; Ellis-Jones J; Abrams P
    J Urol; 2005 Nov; 174(5):1887-91. PubMed ID: 16217330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GreenLight HPS™ 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation.
    Pereira-Correia JA; de Moraes Sousa KD; Santos JB; de Morais Perpétuo D; Lopes-da-Silva LF; Krambeck RL; Muller VJ; Vaz FP
    BJU Int; 2012 Oct; 110(8):1184-9. PubMed ID: 22257240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up?
    Rigatti L; Naspro R; Salonia A; Centemero A; Ghezzi M; Guazzoni G; Briganti A; Rigatti P; Montorsi F
    Urology; 2006 Jun; 67(6):1193-8. PubMed ID: 16750253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and Harms of Benign Prostatic Obstruction Treatments in Renal Transplanted Patients.
    Zakri RH; Hevia V; Bossier R; Rodriguez-Faba O; Garcia EL; Budde K; Breda A; Olsburgh J; Figueiredo A
    Eur Urol Focus; 2023 Nov; 9(6):913-919. PubMed ID: 37596113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urodynamic Effects of Prostatic Urethral Lift Procedure for Male Voiding Lower Urinary Tract Symptoms.
    Muller BG; Martens FMJ; Heesakkers JPFA; d'Ancona FCH
    J Endourol; 2021 Dec; 35(12):1813-1817. PubMed ID: 34314260
    [No Abstract]   [Full Text] [Related]  

  • 16. Hybrid laser treatment compared with transurethral resection of the prostate for symptomatic bladder outlet obstruction caused by a large benign prostate: a prospective, randomized trial with a 6-month follow-up.
    Tuhkanen K; Heino A; Alaopas M
    BJU Int; 1999 Nov; 84(7):805-9. PubMed ID: 10532976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of preoperative urodynamic parameters on clinical results in patients with benign prostatic hyperplasia after transurethral resection of the prostate.
    Yang J; Song H; Zhan H; Ding M; Luan T; Chen J; Wei H; Wang J
    World J Urol; 2023 Dec; 41(12):3679-3685. PubMed ID: 37861815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and safety outcomes after benign prostatic enlargement surgeries in men with detrusor underactivity compared with normal detrusor contractility: Systematic review and meta-analysis.
    Wroclawski ML; Takemura LS; Santos HOD; Heldwein FL; Gauhar V; Lim EJ; Law YXT; Teoh JY; Herrmann TRW; Castellani D
    Neurourol Urodyn; 2024 Jan; 43(1):126-143. PubMed ID: 38010924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-1 adrenergic antagonists, 5-alpha reductase inhibitors, phosphodiesterase type 5 inhibitors, and phytotherapic compounds in men with lower urinary tract symptoms suggestive of benign prostatic obstruction: A systematic review and meta-analysis of urodynamic studies.
    Fusco F; Creta M; De Nunzio C; Gacci M; Li Marzi V; Finazzi Agrò E
    Neurourol Urodyn; 2018 Aug; 37(6):1865-1874. PubMed ID: 29603785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Consequences of prostatic obstruction on bladder function, impact of removal, and management of recurrence after surgery].
    de la Taille A; Robert G; Descazeaud A
    Prog Urol; 2018 Nov; 28(15):813-820. PubMed ID: 30262261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.